Thomas Payne, HCA Healthcare’s national medical director of robotics, explains how the largest U.S. health system is vetting a new crop of market entrants.
The global vertebroplasty and kyphoplasty devices market is set for steady expansion, registering a compound annual growth rate (CAGR) of 4.4% from 2022 to 2032. The increasing demand for these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback